Moxifloxacin Tablets 400 Mg – Praiva 400 Tablets

PRAIVA 400 Tablets
Composition:- Moxifloxacin 400 mg.

PRAIVA 400 Tablets – Moxifloxacin Tablets 400 Mg is a fourth-generation fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication and repair. Its broad-spectrum profile and once-daily dosing make it suitable for treating community-acquired pneumonia, complicated skin infections, and intra-abdominal infections.

Key Points of Moxifloxacin Tablets 400 Mg – PRAIVA 400 Tablets
• Broad-Spectrum Bactericidal Activity – Effective against both gram-positive and gram-negative organisms, including atypical pathogens and Mycobacterium avium complex.
• Superior Tissue Penetration – Achieves high concentration in lung, sinus, and abdominal tissues—ideal for respiratory, ENT, and intra-abdominal infections.
• Oral Formulation Tablet – 400 mg oral tablet delivers efficacy comparable to IV infusion, ensuring reliable therapeutic outcomes.

Can be Prescribed by:
• Infectious Disease Specialists
• Pulmonologists / Respiratory Physicians
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.